Momentus Inc. experienced a dramatic surge in its stock price late Tuesday, jumping 96.6% to $14.51 after the company filed to register up to $200 million in securities for potential sale. The stock reached a session high of $15.34, with trading volume exploding to 74.5 million shares—nearly doubling the stock's average volume.
The filing, a Form S-3 shelf registration, allows Momentus to sell various types of securities—including common and preferred stock, debt, warrants, or units—at its discretion, pending additional paperwork. The company noted that the last reported Nasdaq price for its shares was $7.38 as of May 22, and the market value of stock held by non-affiliates stood at approximately $79.8 million.
This move comes as Momentus seeks to shift investor focus toward government space contracts and balance sheet improvement while retaining the option to raise additional capital. The shelf registration appeared on the company's investor relations page alongside a Form 4 disclosure detailing insider trading activity.
Director Chris Hadfield, through his company Hadfield Inc., purchased 2,000 Class A shares at $7.19 each on May 21, according to a Form 4 filing Tuesday. This transaction increased his total holdings to 3,500 shares, signaling confidence from a key board member.
The stock's rally follows shareholder approval for expanded equity incentives. A Form 8-K filed May 22 revealed that shareholders voted to add 500,000 shares to the 2021 Equity Incentive Plan, bringing the total to 560,260, and raised the annual “evergreen” share increase from 3% to 5% of outstanding stock.
Momentus has been actively promoting its contract pipeline to investors in recent weeks. CEO John Rood, in a May 5 update, emphasized “disciplined execution” as the company targets $10 million in revenue for 2026, up from $1.1 million in 2025. Cash reserves stood at $26.2 million as of April 23, and the company cleared its last convertible debt by April 17.
The Vigoride orbital service vehicle remains central to Momentus’s strategy. In late April, the company announced that Vigoride 8 had passed Preliminary Design Review for a fully booked mission in early 2027, supported by two NASA contracts. Tom Malko, senior vice president of engineering and operations, described the design as “sound and ready to advance.”
Momentus’s stock performance outpaced its space industry peers. Rocket Lab USA rose 4.7%, while Intuitive Machines dropped 8.6%. The broader market, as measured by the SPDR S&P 500 ETF Trust, added 0.7%.
However, the rally introduces a familiar risk: dilution. If Momentus takes advantage of the higher share price to sell more stock or securities tied to the stock, existing shareholders could see their ownership stakes reduced. The company raised about $5 million in April through a private placement at $3.75 per share or equivalent, stating it may use the funds for general purposes like working capital.
The immediate question for investors is whether this surge reflects a revaluation of the company’s contract pipeline, a short squeeze, or a combination of both. Momentus has provided a revenue target; now the market is watching whether milestone payments and actual mission work materialize quickly enough to meet it.
